(A30.2) Borderline tuberculoid leprosy

Borderline tuberculoid leprosy is an infectious disease caused by the mycobacterium leprae bacteria. it is characterized by the presence of hypopigmented skin lesions, loss of sensation in the affected area, and mild inflammation of the peripheral nerves. this form of leprosy is less severe than the tuberculoid form, but can still lead to serious complications if left untreated.

Borderline tuberculoid leprosy is caused by mycobacterium leprae, a slow-growing, acid-fast bacillus that is transmitted through contact with nasal secretions or skin lesions of an infected individual. it is characterized by an immune response that is stronger than that seen in lepromatous leprosy, resulting in a granulomatous reaction and the formation of skin lesions. these lesions may be either hypopigmented or erythematous, and they often contain bacilli. in addition, nerve damage can occur due to the infiltration of the bacilli into the nerves.

More details coming soon

• Physical Examination
• Skin Smear Test
• Blood Tests
• X-Ray
• CT Scan
• MRI Scan
• Skin Biopsy

Additions:

• Urine Test
• Stool Test

Main Goal: To reduce the number of bacteria and prevent the spread of the disease

• Prescribe appropriate antibiotics to reduce the number of bacteria
• Administer corticosteroids to reduce inflammation
• Provide patient education about the disease and prevention
• Monitor patient's progress and adjust treatment as needed
• Provide physical and occupational therapy to improve function and mobility
• Provide psychological support to help the patient cope with the disease
• Refer patient to a specialist for surgical interventions when needed

Borderline tuberculoid leprosy can be prevented by practicing good hygiene, avoiding contact with people with leprosy, using insect repellent to reduce the risk of exposure to the bacteria that cause leprosy, getting regular check-ups for early diagnosis and treatment, and receiving the bcg vaccine.